The role of the TSC Alliance in advancing therapy development: a patient organization perspective
Therapeutic Advances in Rare Disease · 2024-01 · 5
DOI: 10.1177/26330040241265411 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Therapeutic Advances in Rare Disease, online erschienen am 25.07.2024. Verfasst von Steven L Roberds und 6 weiteren Autor:innen. Beteiligte Einrichtung: TSC Alliance, 8737 Colesville Road, Silver Spring, MD 20910, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Tuberous sclerosis complex (TSC) is a genetic disease leading to malformations, or tubers, in the cerebral cortex and growth of tumors, most frequently in the brain, heart, kidneys, skin, and lungs. Changes in the brain caused by TSC usually have the biggest negative impact on quality of life. Approximately 85% of individuals with TSC have epilepsy, and TSC-associated neuropsychiatric disorders (TAND) affect nearly all individuals with TSC in some way. TSC Alliance’s research strategy is built upon both funding and catalyzing research. Through grants, the organization provides funding directly to researchers through a competitive application process. The organization has also built a set of resources available to researchers worldwide, including a Natural History Database, Biosample Repository, and Preclinical Consortium. These resources catalyze research because they are available to qualified academic or industry researchers around the world, enabling an almost unlimited number of scientists to access data and resources to enable and accelerate research on TSC. This research strategy continues to be shaped by the needs and priorities of the TSC community, working toward a future where everyone affected by TSC can live their fullest lives.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- TSC Alliance, 8737 Colesville Road, Silver Spring, MD 20910, USA.
- TSC Alliance, Silver Spring, MD, USA.
ORCID-Profile: Steven L Roberds, Zoë Fuchs, Ashley J Pounders
Zitieren
APA
Roberds, S. L., Fuchs, Z., Cassidy, E. M., Metzger, S., Abi, A., Pounders, A. J., & Aguiar, D. J. (2024). The role of the TSC Alliance in advancing therapy development: a patient organization perspective. Therapeutic Advances in Rare Disease, 5. https://doi.org/10.1177/26330040241265411
Vancouver
Roberds SL, Fuchs Z, Cassidy EM, Metzger S, Abi A, Pounders AJ, et al. The role of the TSC Alliance in advancing therapy development: a patient organization perspective. Therapeutic Advances in Rare Disease. 2024;5. doi:10.1177/26330040241265411
BibTeX
@article{Roberds2024,
author = {Roberds, Steven L and Fuchs, Zoë and Cassidy, Elizabeth M and Metzger, Samantha and Abi, Ayat and Pounders, Ashley J and Aguiar, Dean J},
title = {The role of the TSC Alliance in advancing therapy development: a patient organization perspective},
journal = {Therapeutic Advances in Rare Disease},
year = {2024},
volume = {5},
doi = {10.1177/26330040241265411}
}
EUVIMED